CCNG1 and cancer: The vector then enters the target cell and delivers its cytocidal CCNG1 inhibitor gene (payload) into the nucleus of rapidly dividing cancer cells, TAFs and neoangiogenic cells, causing cell death via apoptosis-mediated pathways (Morse et al., 2021).